Company Allegedly Lied to Doctors and Public Health Care Benefit Programs About the Safety and Diversion Risks of Suboxo
Outcome
OIG enforcement action against Company Allegedly Lied to Doctors and Public Health Care Benefit Programs About the Safety and Diversion Risks of Suboxo for controlled substance.
Details
Company Allegedly Lied to Doctors and Public Health Care Benefit Programs About the Safety and Diversion Risks of Suboxo — OIG Enforcement (2026)
OIG took enforcement action against Company Allegedly Lied to Doctors and Public Health Care Benefit Programs About the Safety and Diversion Risks of Suboxo in VA in 2026 involving controlled substance violations in the Independent Pharmacies sector.
Violation types: Controlled Substance
Entity type: Pharmacy
Penalty type: Settlement
Location: VA
Source: Company Allegedly Lied to Doctors and Public Health Care Benefit Programs About the Safety and Diversion Risks of Suboxone Film
How Crucible Prevents This
Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works